BRCA1 and BRCA2 (panel of core mutations)
Material: Blood
Test price: PLN 520
Waiting time for results: result after 25 working days
Reservation:
Test price: PLN 520
Waiting time for results: result after 25 working days
Reservation:
- We only perform testing at selected collection points/hours – PLEASE NOTE! Check testing hours and where appointments are required.
Preparation for the examination
General
- The material for testing is blood.
- The patient does not need to fast. It is recommended to drink a glass of water approximately 30 minutes before the examination.
Important
Samples brought from outside are not accepted for testing.
Description
The test detects mutations in the BRCA1 genes, which predispose to breast or ovarian cancer; it is intended for women with a family history of breast or ovarian cancer.
Detection of a mutation (>1% of women) is an indication for more frequent screening and elimination of other risk factors (e.g., smoking, stress, hormone therapy).
Recent reports indicate that BRCA gene mutations can also cause other cancers, including prostate and pancreatic cancer.
The test detects mutations in the BRCA 2 gene, which predispose to breast or ovarian cancer; it is intended for women with a family history of breast or ovarian cancer.
It is estimated that carrying a BRCA1 gene mutation has a 70% chance of developing breast cancer and a 40% chance of developing ovarian cancer. This translates to a 10-fold increased risk of breast cancer and a 20-fold increased risk of ovarian cancer compared to the average woman. The risk associated with BRCA2 gene mutations is lower, approximately 56% for breast cancer and 27% for ovarian cancer.
Detection of a mutation (>1% of women) is an indication for more frequent screening and elimination of other risk factors (e.g., smoking, stress, hormone therapy).
Detection of a mutation (>1% of women) is an indication for more frequent screening and elimination of other risk factors (e.g., smoking, stress, hormone therapy).
Recent reports indicate that BRCA gene mutations can also cause other cancers, including prostate and pancreatic cancer.
The test detects mutations in the BRCA 2 gene, which predispose to breast or ovarian cancer; it is intended for women with a family history of breast or ovarian cancer.
It is estimated that carrying a BRCA1 gene mutation has a 70% chance of developing breast cancer and a 40% chance of developing ovarian cancer. This translates to a 10-fold increased risk of breast cancer and a 20-fold increased risk of ovarian cancer compared to the average woman. The risk associated with BRCA2 gene mutations is lower, approximately 56% for breast cancer and 27% for ovarian cancer.
Detection of a mutation (>1% of women) is an indication for more frequent screening and elimination of other risk factors (e.g., smoking, stress, hormone therapy).
Preparation and development of material (applies only to contractors)
1034
